Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NMT, AGA Medical Pursue PFO Indication Following Septal Defect Approvals

This article was originally published in The Gray Sheet

Executive Summary

Nitinol Medical Technologies' CardioSeal approval for ventricular septal defects Dec. 5 paves the way for pursuit of expanded approval to treat the much larger population with patent foramen ovale, the firm says

You may also be interested in...



NMT Looking To Broaden STARFlex Indication In Wake Of Panel Outcome

NMT Medical is in discussions with FDA on the design of a trial to support a general stroke-prevention indication for its STARFlex patent foramen ovale (PFO) occluder

NMT Looking To Broaden STARFlex Indication In Wake Of Panel Outcome

NMT Medical is in discussions with FDA on the design of a trial to support a general stroke-prevention indication for its STARFlex patent foramen ovale (PFO) occluder

NMT STARFlex Single-Arm Study Insufficient For Approval, Panel Concludes

NMT Medical must conduct a randomized controlled trial of the STARFlex septal occlusion system to demonstrate that the device is superior to medical therapy in preventing strokes, FDA's Circulatory System Devices Panel concluded at its Sept. 10 meeting in Gaithersburg, Maryland

Related Content

UsernamePublicRestriction

Register

MT015821

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel